AU2014340006B2 - Chitosan stenting paste - Google Patents

Chitosan stenting paste Download PDF

Info

Publication number
AU2014340006B2
AU2014340006B2 AU2014340006A AU2014340006A AU2014340006B2 AU 2014340006 B2 AU2014340006 B2 AU 2014340006B2 AU 2014340006 A AU2014340006 A AU 2014340006A AU 2014340006 A AU2014340006 A AU 2014340006A AU 2014340006 B2 AU2014340006 B2 AU 2014340006B2
Authority
AU
Australia
Prior art keywords
paste
water
osmolality
soluble chitosan
reducing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014340006A
Other languages
English (en)
Other versions
AU2014340006A1 (en
Inventor
Jennifer Gates Medina
Ethan Glenn Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Xomed LLC
Original Assignee
Medtronic Xomed LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/061,993 external-priority patent/US9192692B2/en
Application filed by Medtronic Xomed LLC filed Critical Medtronic Xomed LLC
Publication of AU2014340006A1 publication Critical patent/AU2014340006A1/en
Application granted granted Critical
Publication of AU2014340006B2 publication Critical patent/AU2014340006B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0071—Plasticisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers & Plastics (AREA)
AU2014340006A 2013-10-24 2014-10-23 Chitosan stenting paste Active AU2014340006B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14/061,993 2013-10-24
US14/061,993 US9192692B2 (en) 2013-10-24 2013-10-24 Chitosan stenting paste
US14/319,901 US9192574B2 (en) 2013-10-24 2014-06-30 Chitosan paste wound dressing
US14/319,901 2014-06-30
PCT/US2014/062029 WO2015061606A1 (en) 2013-10-24 2014-10-23 Chitosan stenting paste

Publications (2)

Publication Number Publication Date
AU2014340006A1 AU2014340006A1 (en) 2016-05-12
AU2014340006B2 true AU2014340006B2 (en) 2018-06-28

Family

ID=51862592

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2014340006A Active AU2014340006B2 (en) 2013-10-24 2014-10-23 Chitosan stenting paste
AU2014340012A Active AU2014340012B2 (en) 2013-10-24 2014-10-23 Chitosan paste wound dressing

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2014340012A Active AU2014340012B2 (en) 2013-10-24 2014-10-23 Chitosan paste wound dressing

Country Status (7)

Country Link
US (1) US9192574B2 (cg-RX-API-DMAC7.html)
EP (2) EP3060266B1 (cg-RX-API-DMAC7.html)
JP (2) JP6491647B2 (cg-RX-API-DMAC7.html)
AU (2) AU2014340006B2 (cg-RX-API-DMAC7.html)
CA (2) CA2926401C (cg-RX-API-DMAC7.html)
ES (2) ES2765348T3 (cg-RX-API-DMAC7.html)
WO (2) WO2015061606A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
US8668899B2 (en) 2009-11-13 2014-03-11 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
CA2914610C (en) 2013-03-13 2022-08-02 University Of Maryland Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
CN108610437A (zh) 2013-03-14 2018-10-02 金珂生物医疗公司 生物相容的和生物可吸收的衍生的壳聚糖组合物
EP3341081B1 (en) 2015-08-27 2020-11-11 PrecisionBiotics Group Limited Use of bifidobacterium longum and an exopolysaccharide produced thereby
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
ES2867230T3 (es) * 2016-10-26 2021-10-20 Biointelligence Systems S L Composición bioactiva ósea y usos de la misma
WO2020162764A1 (en) * 2019-02-08 2020-08-13 Chitogel Limited Surgical hydrogel
US11826863B2 (en) 2019-11-04 2023-11-28 Covidien Lp Systems and methods for treating aneurysms
EP4308013A1 (en) 2021-03-16 2024-01-24 Covidien LP Injectable biopolymer compositions and associated systems and methods
EP4084580A1 (en) * 2021-04-30 2022-11-02 Koninklijke Philips N.V. A light output system and design method
KR102852787B1 (ko) * 2021-12-28 2025-08-28 단국대학교 천안캠퍼스 산학협력단 신규한 화합물을 포함하는 생리 식염수
WO2024102389A1 (en) * 2022-11-10 2024-05-16 Hemostasis, Llc Dressing formulations
CN116059430B (zh) * 2022-12-16 2025-09-23 无锡学院 一种可降解伤口敷料及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013284A1 (en) * 1994-10-28 1996-05-09 Innovative Technologies Limited Wound treatment composition
WO1999007416A1 (en) * 1997-08-04 1999-02-18 Bio-Syntech Ltd. TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS
WO2002040072A2 (en) * 2000-11-15 2002-05-23 Bio Syntech Canada Inc. Filler composition for soft tissue augmentation and reconstructive surgery
US20030143274A1 (en) * 1991-10-30 2003-07-31 Viegas Tacey X. Medical uses of in situ formed gels
WO2010033943A1 (en) * 2008-09-19 2010-03-25 The Trustees Of The University Of Pennsylvania Biodegradable stent
WO2011060545A1 (en) * 2009-11-19 2011-05-26 Corporation De L'ecole Polytechnique De Montreal Specific blood:chitosan mixing ratios producing a viscous paste-like implant with good handling properties for tissue repair

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394373A (en) 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
US4532134A (en) 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US4452785A (en) 1982-11-08 1984-06-05 Malette William Graham Method for the therapeutic occlusion
CA1202904A (en) 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
US4659700A (en) 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
JPH0735281B2 (ja) 1988-02-16 1995-04-19 学校法人松本歯科大学 硬化性組成物
US4956350A (en) 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
US5124151A (en) 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5871985A (en) 1992-09-28 1999-02-16 Brown University Research Foundation Particulate non cross-linked chitosan core matrices for encapsulated cells
GB2276819B (en) 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
US5531716A (en) 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
US5622834A (en) 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
SE9402531L (sv) 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
USRE38431E1 (en) 1995-12-01 2004-02-17 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US6344077B1 (en) 1997-05-13 2002-02-05 Young-Keun Hong Aqueous cellulose solution and rayon fiber produced from the same
US6458375B1 (en) 1998-02-27 2002-10-01 Musculoskeletal Transplant Foundation Malleable paste with allograft bone reinforcement for filling bone defects
AU1848601A (en) 1999-12-09 2001-06-18 Bio Syntech Canada Inc Mineral-polymer hybrid composition
NZ523763A (en) 2000-06-29 2005-02-25 Biosyntech Canada Inc Compostion and method for the repair and regeneration of cartilage and other tissues
EP1190702A1 (en) 2000-09-22 2002-03-27 Ciba SC Holding AG Chitosan emulsion formulation
US20020058704A1 (en) 2000-11-15 2002-05-16 Kimberly-Clark Worldwide, Inc. Multicomponent compositions containing chitosan and methods of preparing same
ATA13842001A (de) 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
WO2003042250A1 (en) 2001-11-15 2003-05-22 Biosyntech Canada Inc. Composition and method to homogeneously modify or cross-link chitosan under neutral conditions
JP3947391B2 (ja) 2001-11-28 2007-07-18 独立行政法人 日本原子力研究開発機構 橋かけ構造を有するキチン誘導体及び／又はキトサン誘導体の製造方法
FR2836044A1 (fr) 2002-02-15 2003-08-22 Octaris Composition pour la reparation et la cicatrisation cutanee comprenant exclusivement un vrai hydrogel physique de chitosane
US20060127873A1 (en) 2002-07-16 2006-06-15 Caroline Hoemann Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
AU2003271132A1 (en) 2002-10-08 2004-05-04 Ricom Corporation Chitosan-containing polysaccharide, process for producing the same and use thereof
JP2006347883A (ja) * 2003-09-08 2006-12-28 Neetec:Kk 糖鎖含有キトサン誘導体及びグリコサミノグリカンを含有する医療用組成物
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
GB0329918D0 (en) 2003-12-24 2004-01-28 West Pharm Serv Drug Res Ltd Intranasal compositions
GB0403938D0 (en) 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
JP2005281654A (ja) * 2004-03-31 2005-10-13 Rikogaku Shinkokai 温度応答性組成物およびそのヒドロゲル
ITRM20040539A1 (it) 2004-11-02 2005-02-02 Mavi Sud S R L Preparati a base di chitina o suoi derivati per uso cosmetico o medico.
RU2007122799A (ru) 2004-12-20 2009-01-27 КарбГрафт АБ (SE) Хитозановые композиции
WO2007002345A2 (en) 2005-06-21 2007-01-04 Bausch & Lomb Incorporated Method for improving water solubility of chitosan
US20090149421A1 (en) 2005-11-04 2009-06-11 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
EP1986692B1 (en) 2006-01-25 2018-03-07 University Of Virginia Patent Foundation Methods for regulating gelation of chitosan solutions and uses thereof
CA2643322C (en) 2006-02-24 2015-07-21 Novartis Ag Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US20070264296A1 (en) 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
WO2008127287A2 (en) 2006-10-11 2008-10-23 Biolife, L.L.C. Materials and methods for wound treatment
US8153612B2 (en) 2006-12-11 2012-04-10 Chi2Gel Ltd. Injectable chitosan mixtures forming hydrogels
US20100178313A1 (en) 2007-06-13 2010-07-15 Fmc Corporation Implantable Degradable Biopolymer Fiber Devices
US8703924B2 (en) 2007-10-30 2014-04-22 Viscogel, AB Chitosan composition
JP2011513034A (ja) 2008-03-10 2011-04-28 マーフライ・２・リミテッド・パートナーシップ 骨セメント組成物
AU2009240513B2 (en) 2008-04-24 2015-03-26 Medtronic, Inc. Chitosan-containing protective composition
CN102216381B (zh) 2008-04-24 2016-06-15 麦德托尼克公司 可再水化的多糖颗粒和海绵体
AU2009240511B2 (en) 2008-04-24 2015-01-22 Medtronic, Inc. Thiolated chitosan gel
EP2303254B1 (en) 2008-06-12 2019-10-30 Medtronic Xomed, Inc. Product for treating chronic wounds with an extracellular polymeric substance solvating system
CA2806559C (en) 2009-09-02 2018-06-26 Synedgen Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
US9427469B2 (en) 2009-11-19 2016-08-30 Ortho Regenerative Technologies Inc. Soluble physiological chitosan formulations combined with platelet-rich plasma (PRP) for tissue repair
CN102469782A (zh) 2010-06-18 2012-05-23 哈洛资源公司 包含壳聚糖的固态共混物的制剂及方法
US8506972B2 (en) 2010-08-27 2013-08-13 Oligo Medic Inc Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143274A1 (en) * 1991-10-30 2003-07-31 Viegas Tacey X. Medical uses of in situ formed gels
WO1996013284A1 (en) * 1994-10-28 1996-05-09 Innovative Technologies Limited Wound treatment composition
WO1999007416A1 (en) * 1997-08-04 1999-02-18 Bio-Syntech Ltd. TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS
WO2002040072A2 (en) * 2000-11-15 2002-05-23 Bio Syntech Canada Inc. Filler composition for soft tissue augmentation and reconstructive surgery
WO2010033943A1 (en) * 2008-09-19 2010-03-25 The Trustees Of The University Of Pennsylvania Biodegradable stent
WO2011060545A1 (en) * 2009-11-19 2011-05-26 Corporation De L'ecole Polytechnique De Montreal Specific blood:chitosan mixing ratios producing a viscous paste-like implant with good handling properties for tissue repair

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHELLADURAI S et al., 'Design and Evaluation of Bioadhesive in-Situ Nasal Gel of Ketorolac Tromethamine', Chemical & Pharmaceutical Bulletin. 2008, vol. 56, no. 11, pages 1596-1599 *

Also Published As

Publication number Publication date
WO2015061612A1 (en) 2015-04-30
JP6397491B2 (ja) 2018-09-26
US20150119358A1 (en) 2015-04-30
JP6491647B2 (ja) 2019-03-27
JP2016534050A (ja) 2016-11-04
CA2926401C (en) 2019-08-20
CA2926401A1 (en) 2015-04-30
ES2765348T3 (es) 2020-06-08
US9192574B2 (en) 2015-11-24
CA2927357A1 (en) 2015-04-30
JP2016533775A (ja) 2016-11-04
ES2755137T3 (es) 2020-04-21
EP3060266B1 (en) 2019-09-04
AU2014340012B2 (en) 2018-06-28
EP3060265A1 (en) 2016-08-31
EP3060266A1 (en) 2016-08-31
WO2015061606A1 (en) 2015-04-30
EP3060265B1 (en) 2019-11-27

Similar Documents

Publication Publication Date Title
AU2014340006B2 (en) Chitosan stenting paste
AU2014340006A1 (en) Chitosan stenting paste
US9192692B2 (en) Chitosan stenting paste
US12419989B2 (en) Solid solution compositions comprising cannabidiols
AU2014340012A1 (en) Chitosan paste wound dressing
AU2009240510B2 (en) Rehydratable polysaccharide particles and sponge
AU2009240511B2 (en) Thiolated chitosan gel
US20090270346A1 (en) Protective gel based on chitosan and oxidized polysaccharide
AU2009240509B2 (en) Rehydratable thiolated polysaccharide particles and sponge

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)